| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
5,374 |
4,958 |
$3.07M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
20,766 |
17,181 |
$1.28M |
| 93017 |
|
2,430 |
2,226 |
$1.08M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
31,551 |
25,539 |
$498K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,802 |
752 |
$437K |
| OP279 |
|
2,424 |
1,878 |
$434K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,045 |
940 |
$356K |
| 94060 |
|
772 |
743 |
$249K |
| 94010 |
|
850 |
763 |
$191K |
| 94729 |
|
1,125 |
1,056 |
$125K |
| 93226 |
|
461 |
459 |
$123K |
| OP250 |
|
20,878 |
4,184 |
$117K |
| 93225 |
|
461 |
459 |
$109K |
| 71250 |
|
388 |
366 |
$98K |
| 93880 |
|
299 |
276 |
$78K |
| 93923 |
|
261 |
258 |
$66K |
| 93356 |
|
2,204 |
1,929 |
$65K |
| 71046 |
Radiologic examination, chest; 2 views |
2,482 |
2,245 |
$65K |
| J2785 |
Injection, regadenoson, 0.1 mg |
647 |
568 |
$63K |
| 36415 |
Collection of venous blood by venipuncture |
17,545 |
12,219 |
$62K |
| 93296 |
|
4,066 |
3,713 |
$55K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,156 |
7,155 |
$54K |
| 93925 |
|
156 |
134 |
$43K |
| 93970 |
|
85 |
82 |
$41K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
2,313 |
479 |
$40K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
520 |
445 |
$39K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
3,338 |
2,900 |
$36K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,554 |
4,556 |
$35K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,978 |
662 |
$35K |
| 94727 |
|
373 |
366 |
$32K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
1,086 |
900 |
$31K |
| 93243 |
|
616 |
551 |
$28K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,197 |
3,666 |
$26K |
| 94618 |
|
498 |
425 |
$25K |
| 82962 |
|
2,564 |
1,071 |
$25K |
| G0378 |
Hospital observation service, per hour |
176 |
107 |
$24K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,572 |
299 |
$23K |
| 80053 |
Comprehensive metabolic panel |
6,191 |
4,927 |
$22K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,817 |
3,099 |
$21K |
| 80061 |
Lipid panel |
4,895 |
4,116 |
$20K |
| OP259 |
|
8,675 |
2,583 |
$19K |
| 93247 |
|
455 |
397 |
$18K |
| 93242 |
|
613 |
550 |
$18K |
| 93304 |
|
70 |
68 |
$15K |
| 95811 |
|
12 |
12 |
$15K |
| 85610 |
|
5,259 |
2,913 |
$14K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,270 |
1,753 |
$14K |
| C1769 |
Guide wire |
725 |
626 |
$13K |
| C1874 |
Stent, coated/covered, with delivery system |
13 |
12 |
$12K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
462 |
411 |
$12K |
| 93246 |
|
452 |
397 |
$11K |
| A4641 |
Radiopharmaceutical, diagnostic, not otherwise classified |
339 |
331 |
$10K |
| 0296T |
|
178 |
177 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
940 |
749 |
$9K |
| 87641 |
|
1,455 |
1,051 |
$8K |
| 0297T |
|
169 |
169 |
$8K |
| OP379 |
|
296 |
226 |
$7K |
| 83880 |
|
1,034 |
758 |
$7K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
32 |
27 |
$6K |
| 75561 |
|
13 |
12 |
$6K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
412 |
314 |
$5K |
| 85730 |
|
985 |
651 |
$5K |
| OP272 |
|
193 |
154 |
$5K |
| 93297 |
|
610 |
549 |
$5K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
142 |
133 |
$4K |
| 0012A |
|
112 |
112 |
$4K |
| 0011A |
|
115 |
115 |
$4K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
13 |
12 |
$4K |
| 0002A |
|
111 |
110 |
$4K |
| 0001A |
|
100 |
99 |
$3K |
| 83735 |
|
2,801 |
1,748 |
$3K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
132 |
25 |
$3K |
| 86850 |
|
828 |
593 |
$2K |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,447 |
694 |
$2K |
| 93299 |
|
214 |
213 |
$2K |
| Q3014 |
Telehealth originating site facility fee |
121 |
112 |
$2K |
| 93298 |
|
147 |
141 |
$1K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,465 |
953 |
$1K |
| 93289 |
|
82 |
71 |
$1K |
| 86901 |
|
828 |
593 |
$1K |
| 84484 |
|
254 |
136 |
$1K |
| C1760 |
Closure device, vascular (implantable/insertable) |
26 |
24 |
$982.66 |
| 86900 |
|
830 |
593 |
$805.53 |
| 93750 |
|
47 |
25 |
$639.04 |
| 87070 |
|
529 |
339 |
$636.00 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
208 |
144 |
$504.78 |
| 84439 |
|
255 |
208 |
$477.59 |
| 71045 |
Radiologic examination, chest; single view |
59 |
36 |
$386.80 |
| C1885 |
Catheter, transluminal angioplasty, laser |
13 |
12 |
$330.29 |
| 93280 |
|
33 |
25 |
$290.94 |
| 93288 |
|
30 |
28 |
$282.41 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
72 |
54 |
$200.71 |
| 85347 |
|
116 |
78 |
$135.75 |
| 87077 |
|
78 |
49 |
$135.12 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
104 |
60 |
$101.82 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
493 |
341 |
$101.03 |
| 80076 |
|
16 |
13 |
$81.05 |
| 87186 |
|
16 |
12 |
$68.82 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
18 |
14 |
$44.28 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
65 |
41 |
$37.88 |
| 87205 |
|
39 |
24 |
$23.08 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
41 |
28 |
$17.47 |
| 82565 |
|
14 |
13 |
$14.61 |
| 83615 |
|
15 |
12 |
$10.10 |
| 85027 |
|
20 |
13 |
$5.04 |
| 84520 |
|
18 |
12 |
$4.00 |
| 85007 |
|
20 |
13 |
$2.52 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
23 |
15 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
76 |
46 |
$0.00 |